No Data
No Data
Shares of Pharmaceutical Stocks Are Trading Lower. The Sector May Down on Continued Weakness Amid President Trump's Drug Pricing Executive Order.
Unpacking the Latest Options Trading Trends in Eli Lilly
Verve Therapeutics Shares Are Trading Higher After the Company Reported a Year-over-year Increase for Q1 EPS Results.
Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Has Been Granted To BEAM-302 For The Treatment Of Alpha-1 Antitrypsin Deficiency